Event Details I Sep 3–4, 2026
Event Details I Sep 3–4, 2026
International Summit on Cellular Immunotherapy 2026: From Discovery to Therapeutic Breakthroughs
Date: 3–4 September 2026
Venue: Faculty of Medicine, Prince of Songkla University (PSU), Hat Yai, Songkhla, Thailand
Hosted by: SCT-PSU (Stem Cell Transplantation and Cellular Therapy Excellence Center) x Thailand Hub of Talents in Cancer Immunotherapy (TTCI)
Overview
Join global pioneers, clinical researchers, and biotech leaders at the International Summit on Cellular Immunotherapy 2026. This premier two-day event bridges the gap between laboratory innovation and bedside reality, showcasing the latest breakthroughs in CAR-T cell engineering, myeloid niche reprogramming, and precision oncology.
Highlighted Sessions & Keynote Tracks
Next-Generation CAR-T & Cellular Evolution
Beyond CD8: CUL5 Knockdown Unleashes CD4+ T Cell Potential for Next-Generation CAR-T Therapy
Speaker: Seitaro Terakura, MD., PhD. (Nagoya University, Japan)
The Next Frontier in Multiple Myeloma: BCMA CAR-T and Evolution of Cellular Therapy
Speaker: Lily Zhou, MD. (Sino United Hospital Shanghai, China)
Clinical-Scale Closed-System CAR T-Cell Manufacturing: From Cell Processing to Product Release
Speaker: Koramit Suppipat, MD. (Chulalongkorn University / Thai Can Biotech Co., Ltd.)
Overcoming Immune Resistance & Tumor Microenvironments
Reprogramming CAF-Myeloid Bone Marrow Niches to Overcome Immune Resistance in Multiple Myeloma
Speaker: Reona Leo Sakemura (Mayo Clinic MN, USA)
Breaking Barriers for CAR-T Therapy in Colorectal Cancer
Speaker: Art Hiranyakas, MD., PhD. (Bangkok Phuket Hospital Co., Ltd.)
Bench to Bedside: Thai Ecosystem & Regulations
Translating CAR-T Cell Innovation from Bench to Bedside: The Roles of Public and Private Sectors
Panelists include leaders from the Department of Medical Services (MOPH), Bangkok Hospital Group 3&6 (BDMS), Chulalongkorn University, and Prince of Songkla University.
National Landscape on ATMPs Regulations and Acceleration Pathways
Speaker: Vip Viprakasit, MD., DPhil. (Siriraj Hospital)
Bringing CAR-T Therapy Closer to Patients Through Point-of-Care Manufacturing in Thailand
Speaker: Jakrawadee Julamanee, MD., PhD. (Diagnostic Everlight Co., Ltd.)
Special Features
Research Showcase: Explore innovative project updates from leading Thai universities (PSU, CU, Siriraj, CMU) covering solid tumors like Cholangiocarcinoma, personalized neoantigen vaccines, and humanized antibodies.
Site Visit: Exclusive facility tour of the TTCI/GMP-compliant facility (7th floor, Internal Medicine Building) incorporating the CRC facility, Medical Hub Service, and TMRC.
Contact & Inquiries
อีเมล: [email protected]
Tel: +66 7445 5000 ext 143970, +66 96 647 1300
